Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Clinical trials sponsored by Chengdu Kanghong Pharmaceutical Group Co., Ltd., explained in plain language.
-
New pain pill KHN702 heads into first human tests
Symptom relief Not yet recruitingThis early-stage trial tests whether KHN702 tablets can safely ease moderate to severe pain after surgery. About 24 adults will receive either the drug or a placebo, and researchers will measure pain relief over 48 hours. The goal is to see if this new pill works and is safe enou…
Phase: PHASE1 • Sponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd. • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC
-
New drug KHN707 enters first human safety tests in china
Knowledge-focused Not yet recruitingThis early-stage study tests whether KHN707 tablets are safe and how they move through the body in 38 healthy Chinese adults aged 18 to 45. Participants are randomly assigned to receive either the drug or a placebo, and no one knows who gets what. The main goal is to check for si…
Phase: PHASE1 • Sponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC